Welcome to our dedicated page for Tandem Diabetes news (Ticker: TNDM), a resource for investors and traders seeking the latest updates and insights on Tandem Diabetes stock.
Tandem Diabetes Care reports developments in automated insulin delivery and diabetes technology. The company manufactures and sells pump systems including Tandem Mobi and the t:slim X2 insulin pump, both powered by Control-IQ+ advanced hybrid closed-loop technology. News commonly covers FDA clearances, pump and mobile-app compatibility, continuous glucose monitoring integrations, and product portfolio updates for people with diabetes.
Company updates also address quarterly and annual operating results, worldwide and U.S. sales trends, pump shipments, gross margin, financial guidance, reimbursement-model changes, investor conference presentations, and capital actions such as convertible debt financing.
Tandem Diabetes Care, Inc. (NASDAQ: TNDM) has announced upcoming presentations at three significant virtual investor conferences. The first will take place at the 29th Annual Credit Suisse Healthcare Conference on November 9, 2020, at 2:00 p.m. ET. The second event is the Stifel 2020 Healthcare Conference on November 17, 2020, at 4:40 p.m. ET. Lastly, the Nasdaq 43rd Investor Conference will occur on December 4, 2020, at 12:30 p.m. ET. Webcasts of these presentations will be available live and archived for 30 days on the company’s Investor Center website.
Tandem Diabetes Care (NASDAQ: TNDM) will announce its third quarter 2020 results on November 5, 2020, after market close. A conference call and webcast will be held at 4:30 PM ET to discuss the financial and operational results. This session can be accessed through a toll-free number or via a webcast link. An archive of the event will be available for 30 days on the company’s Investor Center website. Tandem is known for its innovative insulin delivery systems, notably the t:slim X2 insulin pump.